Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase?

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 81-91

  Shaikh, Sana A ^a   Sahoo, Sanjaya K ^a   Periasamy, Muthu ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Ca2+ transport; Phospholamban; Sarcolipin; SERCA

Indexed keywords

CALCIUM ION; MEMBRANE PROTEIN; PHOSPHOLAMBAN; SARCOLIPIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM BINDING PROTEIN; MUSCLE PROTEIN; PROTEOLIPID;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART DEATH; HEART MUSCLE; HUMAN; MITRAL VALVE REGURGITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; THERMOGENESIS; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; GENE EXPRESSION; GENETICS; ION TRANSPORT; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; GENE EXPRESSION; HUMANS; ION TRANSPORT; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEOLIPIDS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THERMOGENESIS;

EID: 84953256049     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.12.030     Document Type: Review

References (108)

1. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415(6868):198-205.
2. Berchtold M.W., Brinkmeier H., Müntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev. 2000, 80(3):1215-1265.
3. Aubier M., Viires N. Calcium ATPase and respiratory muscle function. Eur. Respir. J. 1998, 11(3):758-766.
4. Periasamy M., Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 2007, 35(4):430-442.
5. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 2003, 4(7):566-577.
6. Traaseth N.J., et al. Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca2+-ATPase. Biochemistry 2008, 47(1):3-13.
7. Haghighi K., Gregory K.N., Kranias E.G. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 2004, 322(4):1214-1222.
8. Kranias E., Bers D. Calcium and cardiomyopathies. Calcium Signalling and Disease 2007, 523-537. Springer.
9. Kranias E.G., Hajjar R.J. Modulation of cardiac contractility by the phopholamban/SERCA2a regulatome. Circ. Res. 2012, 110(12):1646-1660.
10. Luo W., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 1994, 75(3):401-409.
11. Mall S., et al. The presence of sarcolipin results in increased heat production by Ca2+-ATPase. J. Biol. Chem. 2006, 281(48):36597-36602.
12. Smith W., Broadbridge R., EAST J., LEE A. Sarcolipin uncouples hydrolysis of ATP from accumulation of Ca2+ by the Ca2+-ATPase of skeletal-muscle sarcoplasmic reticulum. Biochem. J. 2002, 361:277-286.
13. Sahoo S.K., Shaikh S.A., Sopariwala D.H., Bal N.C., Periasamy M. Sarcolipin protein interaction with sarco (endo) plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump. J. Biol. Chem. 2013, 288(10):6881-6889.
14. Bal N.C., et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nat. Med. 2012, 18(10):1575-1579.
15. Maurya S.K., et al. Sarcolipin is a key determinant of the basal metabolic rate, and its overexpression enhances energy expenditure and resistance against diet-induced obesity. J. Biol. Chem. 2015, 290(17):10840-10849.
16. Sopariwala D.H., et al. Sarcolipin overexpression improves muscle energetics and reduces fatigue. J. Appl. Physiol. 2015, 118(8):1050-1058.
17. Simmerman H.K., Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 1998, 78(4):921-947.
18. Olesen C., et al. The structural basis of calcium transport by the calcium pump. Nature 2007, 450(7172):1036-1042.
19. Olesen C., Sørensen T.L.-M., Nielsen R.C., Møller J.V., Nissen P. Dephosphorylation of the calcium pump coupled to counterion occlusion. Science 2004, 306(5705):2251-2255.
20. Toyoshima C., Mizutani T. Crystal structure of the calcium pump with a bound ATP analogue. Nature 2004, 430(6999):529-535.
21. Toyoshima C., Nakasako M., Nomura H., Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6Å resolution. Nature 2000, 405(6787):647-655.
22. Toyoshima C., Nomura H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 2002, 418(6898):605-611.
23. Toyoshima C., Nomura H., Sugita Y. Structural basis of ion pumping by Ca2+-ATPase of sarcoplasmic reticulum. FEBS Lett. 2003, 555(1):106-110.
24. Toyoshima C., Nomura H., Tsuda T. Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues. Nature 2004, 432(7015):361-368.
25. Møller J.V., Olesen C., Winther A.-M.L., Nissen P. The sarcoplasmic Ca2+-ATPase: design of a perfect chemi-osmotic pump. Q. Rev. Biophys. 2010, 43(04):501-566.
26. Toyoshima C., Inesi G. Structural basis of ion pumping by Ca2+-ATPase of the sarcoplasmic reticulum. Biochemistry 2004, 73(1):269.
27. Inesi G. Mechanism of calcium transport. Annu. Rev. Physiol. 1985, 47(1):573-601.
28. Hasselbach W. The reversibility of the sarcoplasmic calcium pump. Biochim. Biophys. Acta Rev. Biomembr. 1978, 515(1):23-53.
29. de Meis L. Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. Biosci. Rep. 2001, 21:113-137.
30. Meis L. Ca2+-ATPases (SERCA): energy transduction and heat production in transport ATPases. J. Membr. Biol. 2002, 188(1):1-9.
31. Ld M., Vianna A.L. Energy interconversion by the Ca2+-dependent ATPase of the sarcoplasmic reticulum. Annu. Rev. Biochem. 1979, 48(1):275-292.
32. Tada M., Kirchberger M.A., Katz A.M. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3': 5'-monophosphate-dependent protein kinase. J. Biol. Chem. 1975, 250(7):2640-2647.
33. Tada M., Toyofuku T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc. Med. 1998, 8(8):330-340.
34. Akin B.L., Chen Z., Jones L.R. Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state. J. Biol. Chem. 2010, 285(37):28540-28552.
35. Akin B.L., Hurley T.D., Chen Z., Jones L.R. The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum. J. Biol. Chem. 2013, 288(42):30181-30191.
36. Chen Z., Akin B.L., Jones L.R. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J. Biol. Chem. 2007, 282(29):20968-20976.
37. Chen Z., Akin B.L., Jones L.R. Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban. J. Biol. Chem. 2010, 285(5):3253-3260.
38. Chen Z., Akin B.L., Stokes D.L., Jones L.R. Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain. J. Biol. Chem. 2006, 281(20):14163-14172.
39. Chen Z., Stokes D.L., Jones L.R. Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 2005, 280(11):10530-10539.
40. Chen Z., Stokes D.L., Rice W.J., Jones L.R. Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents. J. Biol. Chem. 2003, 278(48):48348-48356.
41. Jones L.R., Cornea R.L., Chen Z. Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking. J. Biol. Chem. 2002, 277(31):28319-28329.
42. Wegener A., Jones L. Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits. J. Biol. Chem. 1984, 259(3):1834-1841.
43. Chu G., et al. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ. Res. 1997, 81(4):485-492.
44. Koss K.L., Kranias E.G. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 1996, 79(6):1059-1063.
45. Schmitt J.P., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003, 299(5611):1410-1413.
46. Zhai J., et al. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac functionin vivo. J. Biol. Chem. 2000, 275(14):10538-10544.
47. Asahi M., Green N.M., Kurzydlowski K., Tada M., MacLennan D.H. Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco (endo) plasmic reticulum Ca2+ ATPases. Proc. Natl. Acad. Sci. 2001, 98(18):10061-10066.
48. Odermatt A., Kurzydlowski K., MacLennan D.H. The vmax of the Ca2+-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) is not altered by Ca2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J. Biol. Chem. 1996, 271(24):14206-14213.
49. Toyofuku T., Kurzydlowski K., Tada M., MacLennan D.H. Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca(2+)-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J. Biol. Chem. 1994, 269(37):22929-22932.
50. Toyoshima C., et al. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc. Natl. Acad. Sci. 2003, 100(2):467-472.
51. Jones L.R., Besch H., Fleming J.W., McConnaughey M.M., Watanabe A.M. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities. J. Biol. Chem. 1979, 254(2):530-539.
52. Lamers J., Stinis J. Phosphorylation of low molecular weight proteins in purified preparations of rat heart sarcolemma and sarcoplasmic reticulum. Biochim. Biophys. Acta 1980, 624(2):443-459.
53. Bidlack J.M., Shamoo A.E. Adenosine 3', 5'-monophosphate-dependent phosphorylation of a 6000 and A 22000 dalton protein from cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta Gen. Subj. 1980, 632(2):310-325.
54. Will H., Levchenko T.S., Levitsky D.O., Smirnov V.N., Wollenberger A. Partial characterization of protein kinase-catalyzed phosphorylation of low molecular weight proteins in purified preparations of pigeon heart sarcolemma and sarcoplasmic reticulum. Biochim. Biophys. Acta Gen. Subj. 1978, 543(2):175-193.
55. Nicolaou P., Hajjar R.J., Kranias E.G. Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J. Mol. Cell. Cardiol. 2009, 47(3):365-371.
56. Macdougall L.K., Jones L.R., Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 1991, 196(3):725-734.
57. Haghighi K., et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(5):1388-1393.
58. Ha K.N., et al. Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proc. Natl. Acad. Sci. 2011, 108(7):2735-2740.
59. Young H.S., Ceholski D.K., Trieber C.A. Deception in simplicity: Hereditary phospholamban mutations in dilated cardiomyopathy 1. Biochem. Cell Biol. 2014, 93(1):1-7.
60. Haghighi K., et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Investig. 2003, 111(6):869.
61. MacLennan D.H. Isolation of proteins of the sarcoplasmic reticulum. Methods Enzymol. 1974, 32:291.
62. Racker E., Eytan E. A coupling factor from sarcoplasmic reticulum required for the translocation of Ca2+ ions in a reconstituted Ca2+ ATPase pump. J. Biol. Chem. 1975, 250(18):7533-7534.
63. MacLennan D.H., et al. Ion pathways in proteins of the sarcoplasmic reticulum. Ann. N. Y. Acad. Sci. 1980, 358(1):138-148.
64. Wawrzynow A., et al. Sarcolipin, the "proteolipid" of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide. Arch. Biochem. Biophys. 1992, 298(2):620-623.
65. Odermatt A., et al. Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. J. Biol. Chem. 1998, 273(20):12360-12369.
66. Odermatt A., et al. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 1997, 45(3):541-553.
67. Babu G.J., et al. Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility. J. Biol. Chem. 2006, 281(7):3972-3979.
68. Babu G.J., et al. Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility. Proc. Natl. Acad. Sci. 2007, 104(45):17867-17872.
69. Babu G.J., et al. Overexpression of sarcolipin decreases myocyte contractility and calcium transient. Cardiovasc. Res. 2005, 65(1):177-186.
70. Asahi M., et al. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(25):9199-9204.
71. Gramolini A.O., et al. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2446-2451.
72. Houser S.R., Piacentino V., Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J. Mol. Cell. Cardiol. 2000, 32(9):1595-1607.
73. Pant M., Bal N.C., Periasamy M. Cold adaptation overrides developmental regulation of sarcolipin expression in mice skeletal muscle: SOS for muscle-based thermogenesis?. J. Exp. Biol. 2015, 10.1242/jeb.119164.
74. Babu G.J., Bhupathy P., Carnes C.A., Billman G.E., Periasamy M. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J. Mol. Cell. Cardiol. 2007, 43(2):215-222.
75. Schneider J.S., et al. Increased sarcolipin expression and decreased sarco (endo) plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy. J. Muscle Res. Cell Motil. 2013, 34(5-6):349-356.
76. Zheng J., et al. Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation. Circ. Heart Fail. 2014, 7(1):194-202.
77. Shanmugam M., et al. Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc. Res. 2010, 10.1093/cvr/cvq294.
78. Shanmugam M., et al. Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation. Biochem. Biophys. Res. Commun. 2011, 410(1):97-101.
79. Xie L.-H., et al. Ablation of sarcolipin results in atrial remodeling. Am. J. Physiol. Cell Physiol. 2012, 302(12):C1762-C1771.
80. Sahoo S.K., et al. The N terminus of sarcolipin plays an important role in uncoupling sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) ATP hydrolysis from Ca2+ transport. J. Biol. Chem. 2015, 290(22):14057-14067.
81. Lee A.G. A calcium pump made visible. Curr. Opin. Struct. Biol. 2002, 12(4):547-554.
82. Asahi M., Kurzydlowski K., Tada M., MacLennan D.H. Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco (endo) plasmic reticulum Ca2+-ATPases (SERCAs). J. Biol. Chem. 2002, 277(30):26725-26728.
83. Asahi M., Nakayama H., Tada M., Otsu K. Regulation of sarco (endo) plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure. Trends Cardiovasc. Med. 2003, 13(4):152-157.
84. Asahi M., et al. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc. Natl. Acad. Sci. 2003, 100(9):5040-5045.
85. Gramolini A.O., et al. Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca2+-ATPases. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(48):16807-16812.
86. Morita T., et al. Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca2+-ATPase. Biochem. Biophys. Res. Commun. 2008, 369(1):188-194.
87. Inesi G., Lewis D., Ma H., Prasad A., Toyoshima C. Concerted conformational effects of Ca2+ and ATP are required for activation of sequential reactions in the Ca2+ ATPase (SERCA) catalytic cycle. Biochemistry 2006, 45(46):13769-13778.
88. Clarke D.M., Loo T.W., Inesi G., MacLennan D.H. Location of high affinity Ca2+-binding sites within the predicted transmembrane domain of the sarco-plasmic reticulum Ca2+-ATPase.
89. Toyoshima C., et al. Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state. Nature 2013, 495(7440):260-264.
90. Winther A.-M.L., et al. The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm. Nature 2013, 495(7440):265-269.
91. Hellstern S., et al. Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes. J. Biol. Chem. 2001, 276(33):30845-30852.
92. Buffy J.J., et al. Two-dimensional solid-state NMR reveals two topologies of sarcolipin in oriented lipid bilayers. Biochemistry 2006, 45(36):10939-10946.
93. Mascioni A., Karim C., Barany G., Thomas D.D., Veglia G. Structure and orientation of sarcolipin in lipid environments. Biochemistry 2002, 41(2):475-482.
94. Butler J., et al. Phospholamban and sarcolipin are maintained in the endoplasmic reticulum by retrieval from the ER-Golgi intermediate compartment. Cardiovasc. Res. 2007, 74(1):114-123.
95. Hughes E., Clayton J.C., Kitmitto A., Esmann M., Middleton D.A. Solid-state NMR and functional measurements indicate that the conserved tyrosine residues of sarcolipin are involved directly in the inhibition of SERCA1. J. Biol. Chem. 2007, 282(36):26603-26613.
96. Gorski P.A., Glaves J.P., Vangheluwe P., Young H.S. Sarco(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcolipin is encoded in its luminal tail. J. Biol. Chem. 2013, 288(12):8456-8467.
97. Bhupathy P., Babu G.J., Periasamy M. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J. Mol. Cell. Cardiol. 2007, 42(5):903-911.
98. Magny E.G., et al. Conserved regulation of cardiac calcium uptake by peptides encoded in small open reading frames. Science 2013, 341(6150):1116-1120.
99. Autry J.M., et al. Oligomeric interactions of sarcolipin and the Ca-ATPase. J. Biol. Chem. 2011, 286(36):31697-31706.
100. Karim C.B., Zhang Z., Howard E.C., Torgersen K.D., Thomas D.D. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J. Mol. Biol. 2006, 358(4):1032-1040.
101. Gustavsson M., et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban. Proc. Natl. Acad. Sci. 2013, 110(43):17338-17343.
102. Metcalfe E.E., Traaseth N.J., Veglia G. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 2005, 44(11):4386-4396.
103. Traaseth N., Thomas D., Veglia G. Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex. J. Mol. Biol. 2006, 358(4):1041-1050.
104. Bidwell P., Blackwell D.J., Hou Z., Zima A.V., Robia S.L. Phospholamban binds with differential affinity to calcium pump conformers. J. Biol. Chem. 2011, 286(40):35044-35050.
105. James P., Inui M., Tada M., Chiesi M., Carafoli E. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature 1989, 342:90-92.
106. Bhupathy P., Babu G.J., Ito M., Periasamy M. Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes. J. Mol. Cell. Cardiol. 2009, 47(5):723-729.
107. Li J., Bigelow D.J., Squier T.C. Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition. Biochemistry 2004, 43(13):3870-3879.
108. Mahaney J.E., Albers R.W., Waggoner J.R., Kutchai H.C., Froehlich J.P. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition. Biochemistry 2005, 44(21):7713-7724.